Fish oil’s relationship with the prostate is genuinely complicated, and anyone looking for a clean thumbs-up or thumbs-down will be disappointed. Large studies consistently show that eating fish does not prevent prostate cancer from developing, yet men who eat fish regularly appear significantly less likely to die from the disease if they do get it. Meanwhile, a widely reported study found that men with the highest blood levels of omega-3 fats actually had a higher risk of prostate cancer, creating a puzzle that researchers have been picking apart for over a decade. The honest picture depends on what you mean by “good for the prostate,” whether you already have a diagnosis, and possibly even how much you take.
Eating Fish Does Not Prevent Prostate Cancer, but It May Save Lives
The most consistent finding across decades of research is a split: fish consumption has no meaningful effect on whether a man develops prostate cancer in the first place, but it does appear to lower the chances of dying from it. A meta-analysis pooling data from twelve case-control studies and twelve cohort studies found no link between eating fish and a reduction in prostate cancer incidence. But among men who did develop prostate cancer, those who ate the most fish had a roughly 63% lower risk of dying from the disease compared to those who ate the least.1The American Journal of Clinical Nutrition. Fish consumption and prostate cancer risk: a review and meta-analysis A 22-year prospective study of health professionals found the same pattern: fish intake was unrelated to getting prostate cancer, but men who ate fish five or more times per week had about half the risk of prostate cancer death compared to men eating fish less than once a week.2PubMed Central. A 22-year prospective study of fish intake in relation to prostate cancer incidence and mortality
A systematic review examining nearly half a million participants echoed these findings. Most studies looking at cancer risk found some inverse trends with fish intake, but the strongest and most reliable associations were with reduced aggressiveness and reduced mortality rather than outright prevention.3PubMed. Systematic review of prostate cancer risk and association with consumption of fish and fish-oils: analysis of 495,321 participants A Swedish study of men already diagnosed with prostate cancer found that those with the highest intake of marine omega-3 fats were about 40% less likely to die from the disease.4American Journal of Epidemiology. Dietary Fatty Acid Intake and Prostate Cancer Survival in Örebro County, Sweden So the story is not “fish oil prevents prostate cancer.” It is closer to “fish oil may help keep prostate cancer from killing you.”
The SELECT Trial and Why Headlines Got Scary
In 2013, a study from the SELECT trial made headlines by reporting that men with the highest blood levels of long-chain omega-3 fats (EPA, DPA, and DHA combined) had a 43% higher risk of prostate cancer overall and a 71% higher risk of high-grade prostate cancer compared to men with the lowest levels.5PubMed Central. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial The authors themselves stated that these findings confirmed earlier reports and suggested omega-3 fats might be “involved in prostate tumorigenesis.”6JNCI: Journal of the National Cancer Institute. Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial
That sounds alarming, and the study is frequently cited by people cautioning against fish oil supplements. But the finding has important context that rarely makes it into the conversation. The difference in omega-3 blood levels between the highest and lowest groups was small: the mean percentage of total omega-3 fats was about 4.66% in the cancer group versus 4.48% in controls.7PubMed Central. Weighing the Benefits of Fish Oil for Patients With Prostate Cancer: A Subcohort Review From the SELECT Trial That is a razor-thin spread, and the study measured blood levels at a single time point without tracking what the men were actually eating or whether they took supplements. The researchers did not ask participants about fish oil use, so there is no way to know whether the elevated blood levels came from diet, supplements, genetics, or something else entirely. Blood phospholipid levels of omega-3 fats reflect intake over just the previous few weeks and are influenced by many metabolic factors beyond what someone swallows.
Why the Contradictions May Not Actually Contradict
A dose-response meta-analysis of prospective studies tried to untangle what individual omega-3 fats do. The results were anything but uniform. Blood DHA showed a marginal positive association with overall prostate cancer risk. Blood EPA showed a link to aggressive disease specifically. But DPA, a lesser-known omega-3, was associated with reduced prostate cancer risk. And dietary alpha-linolenic acid (ALA), the plant-based omega-3 found in flaxseed and walnuts, showed a weak inverse association with risk.8Journal of Epidemiology. Effect of Individual Omega-3 Fatty Acids on the Risk of Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies In other words, different omega-3 fats may push in different directions depending on the type and stage of cancer.
Another meta-analysis looking specifically at blood levels found that high DPA was linked to lower total prostate cancer risk. However, EPA and DHA together showed a positive association with high-grade tumors, and that finding only emerged after a lower-quality study was removed from the analysis.9PubMed Central. The relevance of serum levels of long chain omega-3 polyunsaturated fatty acids and prostate cancer risk: A meta-analysis The authors of a separate review noted that only two epidemiological studies had even attempted to connect fish oil capsule use to prostate cancer risk. One large prospective study found no association whatsoever. An Icelandic cohort found that men who took fish oil at least once a week had a 57% lower risk of advanced prostate cancer.10Mayo Clinic Proceedings. Omega-3 Fatty Acids and Prostate Cancer The evidence is thin, conflicting, and nowhere near enough to conclude that fish oil supplements cause prostate cancer.
A Recent Trial in Men on Active Surveillance
The most encouraging clinical evidence comes from the CAPFISH-3 trial, published in the Journal of Clinical Oncology. This randomized trial enrolled men with low-risk prostate cancer who were on active surveillance, meaning their cancers were being monitored rather than treated. One group ate a diet high in omega-3 and low in omega-6 fats combined with fish oil supplements, while the control group continued their usual diet. After one year, the fish oil group saw their Ki-67 index, a measure of how quickly cancer cells are dividing, drop by about 15%. In the control group, Ki-67 went up by about 24%. The difference between groups was statistically significant.11PubMed Central. A High Omega-3, Low Omega-6 Diet with Fish Oil for Men with Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial
This is a single trial with a specific population, not proof that fish oil slows all prostate cancers. But it is the kind of direct intervention evidence that observational studies of blood levels cannot provide, and it aligns with the broader pattern: omega-3 fats may not prevent prostate cancer, but they may slow its growth once it exists. The trial also combined fish oil with a dietary shift away from omega-6-heavy foods, so the supplement alone may not have been responsible for the full effect.
The Ratio That May Matter More Than the Dose
Several researchers argue that the absolute amount of omega-3 matters less than its ratio to omega-6 fats, the type of polyunsaturated fats concentrated in vegetable oils, processed foods, and much of the modern Western diet. In cell studies, a low omega-6-to-omega-3 ratio suppressed pathways involved in prostate cancer progression, slowed the shift toward castration-resistant disease, and triggered cancer cell death.12PubMed. A low dietary ratio of omega-6 to omega-3 Fatty acids may delay progression of prostate cancer A small trial in men with prostate cancer showed that a low-fat diet supplemented with fish oil significantly shifted the omega-3-to-omega-6 ratio in both blood and fat tissue, and in a majority of patients it reduced expression of COX-2, an enzyme involved in inflammation and tumor promotion.13Urology. Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer
Mouse studies reinforce this. Mice fed an omega-3-rich diet had significantly smaller prostate tumors than those on an omega-6-heavy diet, with lower expression of inflammatory markers and reduced activity in the NF-kB signaling pathway, which helps cancer cells survive and grow.14PubMed Central. Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression This framing helps explain why fish oil might look risky in an observational study measuring only omega-3 blood levels: without knowing what the omega-6 intake was, you are seeing half the picture. A man could have high omega-3 levels and still have a skewed ratio if his omega-6 intake was also high.
How Omega-3 Fats Work Against Prostate Cancer Cells in the Lab
The biological story is surprisingly clear, even if the population-level data is messy. DHA, the omega-3 fat most abundant in fatty fish, has shown the strongest effects on prostate cancer cells. In lab studies, DHA slowed the proliferation of both androgen-sensitive and androgen-resistant prostate cancer cell lines more effectively than EPA or ALA. It also turned down the expression of fatty acid synthase, an enzyme that prostate cancer cells rely on heavily, and turned up genes involved in programmed cell death.15PubMed Central. Marine- and plant-derived ω-3 fatty acids differentially regulate prostate cancer cell proliferation DHA triggered cell death in prostate cancer cells carrying a mutant p53 gene through a mechanism involving reactive oxygen species generated inside the cells’ own mitochondria.16PubMed Central. The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53 A 2025 study confirmed that DHA suppressed growth in both hormone-sensitive and castration-resistant prostate cancer models by disrupting the cells’ ability to build new fats and by increasing oxidative stress.17Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids. DHA suppresses hormone-sensitive and castration-resistant prostate cancer growth by decreasing de novo lipogenesis
DHA also appears to influence the immune cells around tumors. In one study, DHA blocked macrophages near prostate tumors from adopting a pro-tumor profile, reducing markers that typically help cancer evade the immune system.18Prostate Cancer and Prostatic Diseases. Effect of omega-3 fatty acid diet on prostate cancer progression and cholesterol efflux in tumor-associated macrophages—dependence on GPR120 None of this means that swallowing a fish oil capsule kills cancer in a living person, but it does explain why the mortality benefits seen in large population studies are biologically plausible.
Beyond Cancer: Fish Oil and Enlarged Prostate Symptoms
Prostate cancer is not the only prostate condition men worry about. Benign prostatic hyperplasia, or an enlarged prostate, affects most men as they age, causing urinary symptoms like weak flow, urgency, and frequent nighttime trips to the bathroom. A clinical trial tested whether adding omega-3 fatty acids to standard treatment with tamsulosin and finasteride improved outcomes. The group receiving omega-3 showed greater improvement in symptom scores, urinary flow rates, and prostate volume compared to the standard-treatment-only group, with differences appearing as early as one month and persisting through six months.19PubMed. Combination therapy with omega-3 fatty acids plus tamsulocin and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) Adverse effects were the same in both groups. This is one trial, and it tested omega-3 as an add-on rather than a standalone therapy, but the anti-inflammatory properties of omega-3 fats may genuinely help with a condition driven in part by chronic low-grade inflammation.
Does Fish Oil Affect PSA Levels?
PSA, or prostate-specific antigen, is the blood test most commonly used to screen for prostate cancer. If fish oil changed PSA levels substantially, it could either mask cancer or create false alarms, and that would be important to know. A systematic review of interventional studies found that fish oil supplements did not significantly alter PSA in men with prostate cancer.20PubMed Central. Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review A large cross-sectional analysis with strong statistical power concluded that any association between omega-3 blood levels and PSA was either nonexistent or extremely weak in healthy men.21PubMed. Association between omega-3 fatty acids and serum prostate-specific antigen
One smaller randomized trial did find that EPA supplementation reduced PSA by about 30% from baseline, which sounds dramatic but is harder to interpret clinically because the trial was small and the mechanism is unclear.22British Journal of Nutrition. Effects of EPA, γ-linolenic acid or coenzyme Q10 on serum prostate-specific antigen levels: a randomised, double-blind trial Overall, if you take fish oil, you probably do not need to worry that it is distorting your PSA screening results in either direction.
The Dose Question and the U-Shaped Curve
A 2025 study from the PLCO screening trial found something that helps reconcile the confusing evidence: the relationship between omega-3 intake and prostate cancer mortality followed a U-shaped curve. Risk of dying from prostate cancer dropped as intake increased up to about 0.15 to 0.40 grams per day of omega-3 fats. But above that range, the protective effect began to level off, and very high intakes were associated with slightly less benefit.23Frontiers in Nutrition. Dietary Omega-3 intake may slow prostate cancer progression and reduce mortality risk: evidence from prostate, lung, colorectal, and ovarian cancer screening trial The sweet spot for mortality reduction appeared to be in a moderate range, roughly equivalent to two or three servings of fatty fish per week. This aligns with general cardiovascular guidelines and suggests that more is not necessarily better.
The American Urological Association acknowledges that omega-3 fats, particularly from fish, may have anti-inflammatory properties that could reduce prostate cancer risk, and notes that incorporating fatty fish into the diet or considering supplementation may offer protective benefits.24PubMed Central. Prostate cancer risk reduction: promising prevention practices and insights But no major urological guideline currently recommends fish oil as a treatment or prevention strategy for prostate cancer. The evidence is considered promising but not definitive.
Fish Oil and Hormone Therapy
For men undergoing androgen deprivation therapy, a common treatment for advanced prostate cancer, there is early evidence that omega-3 fats could improve how well the therapy works. An animal study found that dietary omega-3 fats enhanced the response to hormone ablation, increasing cancer cell death and slowing the progression toward castration-resistant disease. Relapse correlated with tumor levels of arachidonic acid, an omega-6 fat, while higher omega-3 content in the tumor appeared protective.25The American Journal of Pathology. Dietary n-3 Polyunsaturated Fatty Acids Enhance Hormone Ablation Therapy in Androgen-Dependent Prostate Cancer Cell studies have shown similar findings: a lower omega-6-to-omega-3 ratio suppresses pathways that help prostate cancer cells survive hormone deprivation.12PubMed. A low dietary ratio of omega-6 to omega-3 Fatty acids may delay progression of prostate cancer This is still preclinical work, but for men already on hormone therapy, the data tilts toward potential benefit rather than harm.
Genetics May Explain Why Results Vary So Much
One underappreciated factor in all of this is genetic variation in how individuals metabolize fatty acids. Variants in the FADS gene cluster, which encodes the enzymes responsible for converting shorter-chain fatty acids into longer-chain ones like DHA and arachidonic acid, can substantially change what happens when two people eat the same amount of fish. A study of prostate tissue found that men carrying certain FADS gene variants had significantly different concentrations of both omega-3 and omega-6 metabolites in their prostate tissue, along with different patterns of epigenetic modification affecting the FADS genes themselves.26PubMed Central. Impact of Genetic and Epigenetic Variations Within the FADS Cluster on the Composition and Metabolism of Polyunsaturated Fatty Acids in Prostate Cancer This means that a fish oil dose that pushes one man’s tissue omega-3 levels into a favorable range could have a very different effect in someone with a different genetic background. It also helps explain why population-level studies produce conflicting results: they are averaging across people whose bodies handle these fats in meaningfully different ways.
Whole Fish Versus Capsules
Most of the population studies showing mortality benefits studied fish consumption, not fish oil supplements. This distinction matters more than it might seem. Whole fish provides not just EPA and DHA but also vitamin D, selenium, and high-quality protein, all of which have their own relationships with prostate health. Fish also displaces other foods in the diet, potentially reducing intake of red and processed meats, which have their own associations with prostate cancer risk. When you pop a capsule, you get the omega-3 fats in isolation without the dietary substitution effect and without the accompanying nutrients.
The limited data on supplements specifically is split. As mentioned earlier, one large prospective study found no association between fish oil supplement use and prostate cancer risk, while an Icelandic cohort found significantly lower risk of advanced disease among regular supplement users.10Mayo Clinic Proceedings. Omega-3 Fatty Acids and Prostate Cancer Until more trials specifically test supplements in well-controlled settings, the safest bet remains getting omega-3 fats from actual fish when possible, with supplements as a reasonable backup for people who do not eat seafood regularly. The evidence does not support taking high-dose fish oil as a prostate cancer prevention strategy, but moderate supplementation in the range used for heart health appears unlikely to cause harm and may offer some benefit for men already managing the disease.